Kalyan Roy: Swirling as a Simple Indicator of Platelet Quality
Kalyan Roy, Transfusion Medicine Specialist at Square Hospitals LTD, shared a post on LinkedIn:
”What if a simple visual check could reliably indicate platelet quality – without complex testing?
Ensuring the quality and viability of platelet concentrates (PCs) remains a fundamental pillar of modern transfusion medicine, directly influencing patient safety and clinical outcomes.
A large multicenter study across 13 centers, evaluating over 5,000 platelet units, highlights a valuable and practical insight: the visual assessment of ‘swirling’ can serve as a reliable, real-time indicator of platelet quality.
Key Observations from the Study
- Strong correlation with optimal pH
Swirling was consistently associated with pH levels between 6.7–7.5, a range linked to effective in vivo platelet survival. - Indicator of compromised platelet integrity
Approximately 69% of units lacking swirling showed pH values outside the acceptable physiological range (<6.4 or >7.6), suggesting reduced viability. - Unexplained subset requiring further research
Nearly 20% of non-swirling units had normal pH values, indicating additional underlying factors influencing platelet quality.
Why This Matters
Swirling reflects the preservation of the platelet’s discoid morphology, essential for optimal hemostatic function.
Its absence often signals transformation into a spherical form-historically associated with diminished viability and clinical performance.
Implications for Clinical Practice
- Enables rapid, bedside-compatible evaluation
- Offers a non-invasive and cost-effective alternative to complex laboratory assays
- Improves operational efficiency in transfusion services
- Maintains high standards of patient safety with minimal resource burden
In an era where healthcare systems must balance efficiency with excellence, adopting validated, low-cost tools like swirling assessment can significantly enhance routine platelet quality monitoring.”

Other posts featuring Kalyan Roy on Hemostasis Today.
-
Jul 14, 2026, 12:08Elvira Grandone: Finding the Right LMWH Dose for Pregnant Patients Suffering From DVT
-
Jul 14, 2026, 12:05Eloïse Laouenan: From Washington to Paris – Join GETBO at ISTH 2026
-
Jul 14, 2026, 12:02Louise St. Germain Bannon: Our first ISTH regulatory session at ISTH 2026
-
Jul 14, 2026, 11:21Malwina Maliszewska: Advancing Coagulation Diagnostics at ISTH 2026
-
Jul 14, 2026, 11:07Mary Cushman: Honoring Outstanding Mentorship at ISTH 2026
-
Jul 14, 2026, 10:53Maha Othman: Advancing the Management of Inherited Thrombocytopenias at ISTH 2026
-
Jul 14, 2026, 10:24Sara Zalghout: The Little Things That Make ISTH 2026 Special
-
Jul 14, 2026, 10:11Joseph R. Shaw: GAUGE Advances FXa Inhibitor Reversal at ISTH 2026
-
Jul 13, 2026, 23:39Yaariv Khaykin: Whole-Person Care Can Strengthen Stroke Prevention in Patients With Atrial Fibrillation